Blog

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog

Breaking Science in Gastrointestinal Cancers with Michel P. Ducreux – ESMO

Photo taken from ESMO/LinkedIn

Jul 22, 2024, 11:36

Breaking Science in Gastrointestinal Cancers with Michel P. Ducreux – ESMO

ESMO shared on LinkedIn:

“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Michel P. Ducreux presents his findings on Sequences of regorafenib and trifluridine/tipiracil after failure of standard therapies for mCRC.
Explore this video and the entire series on OncologyPRO now.”

Source: ESMO/LinkedIn

cancer ESMO gastrointestinal cancers Michel P. Ducreux OncoDaily Oncology

Aug 11, 2024, 13:16

Myeloma Paper of the Day, August 11th, suggested by Robert Orlowski

Aug 11, 2024, 13:12

Bilateral Mastectomy and Breast Cancer Mortality

Aug 11, 2024, 13:07

Oncoinfluencers to Follow on Social Media: Dr. Laura Vater

Aug 11, 2024, 13:07

Targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC - ESTRO

Aug 11, 2024, 13:00

Alabama Access Initiative for O’Neal Comprehensive Cancer Center's Thoracic Oncology Program

Aug 11, 2024, 12:58

Karine Tawagi: Expert panel BCANTT24 on the future of IO in Bladder Cancer

Aug 11, 2024, 12:56

Trastuzumab Deruxtecan in HER2–Expressing BTC - Key points by Arndt Vogel

Aug 11, 2024, 12:54

Asad Rahman: Few tips to make the observership experience better for IMGs

Aug 11, 2024, 12:51

Cathy Eng: The challenge in decision making for 1st line mCRC at the LATAM OncoSummit 2024

Aug 11, 2024, 12:51

Are high-dose steroids for immunotherapy-related toxicity harmful in the long run?

Aug 11, 2024, 12:51

Jonathan Chernoff: Happy to be elected as a fellow of the American Society for Cell Biology

Aug 11, 2024, 12:49

Anirban Maitra: Therapeutic targeting of Syndecan-1 axis in gastrointestinal cancers